Clin2
NCT06993181Likely a fitNot yet recruiting

Comparing a new drug alone and with three components

Healthy

This early-phase study tests how a new investigational drug (DA-5222) is processed by the body, both when given alone and when combined with three other components. It helps researchers find the right dose and check safety in healthy people.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
48 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are a healthy adult volunteer.
  • Your body mass index (BMI) is between 18 and 30.
  • Your weight is at least 50 kg (110 lbs) if you are a man, or 45 kg (99 lbs) if you are a woman.
  • You have no major medical conditions, drug allergies, or history of drug abuse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06993168Not yet recruiting· Phase 1
How food affects a new study drug in healthy adults

This study tests a new investigational drug (DA-5222) in healthy volunteers to see how food affects its absorption. It helps determine the best way to take the medication.

Seoul, South Korea
NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT07538466Not yet recruiting· Phase 1
Study of a new combination drug for healthy volunteers

This trial tests a new drug called AD-123 and compares it to taking two other drugs (AD-1231 and AD-1232) together. It is for healthy adults to see how the body handles the drugs and if they are safe.

Seoul
NCT07691242Not yet recruiting· Phase 1
Study of a new drug for healthy adults

This trial is testing a new medication called DW4421. It's an early-stage study to see how safe the drug is and how it affects healthy people. Participants will receive the drug multiple times to help doctors understand dosing.

Cheongju-si, North Chungcheong
NCT07349589Not yet recruiting· Phase 1
Safety study of an investigational drug in healthy adults

This study tests a new investigational drug to see if it is safe and how the body processes it. It is for healthy adults who are willing to participate in a closely monitored clinical trial.

Cheongju-si
NCT07144176Recruiting· Phase 1
Comparing two drugs in healthy volunteers

This trial compares two similar drugs (DWJ1511 and DWC202501) to see how they are processed by the body and how safe they are. It is for healthy volunteers to help ensure the drugs work the same way.

Seoul

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.